STEREOTAXIS STXS 深 沪
等待开盘 09-04 09:30:00 美东时间
2.71
0.000
0.00%
华盛通- 最 高2.72
- 今 开2.72
- 成交量 27.88万股
- 最 低 2.68
- 昨 收 2.71
- 总市值 2.33亿
- 52周最高 3.051
- 市盈率 静 --
- 换手率 0.32%
- 52周最低 1.54
- 委 比 0.00%
- 总股本 8600.08万
- 历史最高 10.30
- 量 比 0.83
- 振 幅 1.48%
- 历史最低 1.33
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
Stereotaxis announced the successful completion of the world’s first procedures using its MAGiC Sweep™, a robotically-navigated high-density electrophysiology mapping catheter. The procedures were performed by Dr. Raffaele Corbisiero and Dr. Pedram Kazemian at Deborah Heart and Lung Center. The catheter demonstrated stable contact, clear signals, and no ectopy in the ventricle, marking a significant advancement in robotic electrophysiology. MAGiC...
09-02 12:08
Stereotaxis to Present at Upcoming Investor Conferences
<p align="justify">Stereotaxis, a leader in surgical robotics, announced that CEO David Fischel will present at two investor conferences in NYC. On September 10, 2025, he will speak at the H.C. Wainwright Global Investment Conference and be available for one-on-one meetings. The next day, he will attend the Lake Street Capital Best Ideas Growth Conference. Fischel expressed excitement about sharing the company’s technological advancements and gro...
09-02 11:51
Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025
Stereotaxis will showcase its surgical robotics technology at HRX 2025, a digital health conference in Atlanta, Sept 4-6. CEO David Fischel will discuss robot-enhanced electrophysiology, followed by a panel exploring advanced ablation techniques, VR, AI, and automation in heart rhythm care. The company aims to shape an innovative future for electrophysiology.
08-28 11:47
Stereotaxis Earnings Call Highlights Growth and Challenges
Stereotaxis (($STXS)) has held its Q2 earnings call. Read on for the main highl...
08-12 08:53
Stereotaxis Q2 EPS $(0.05) Beats $(0.07) Estimate, Sales $8.798M Beat $7.750M Estimate
Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 30.56 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the
08-08 04:03
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
美股牛股 | 公司获高额股权融资，VWAV飙涨近370%；CELC大涨超167%
公司获高额股权融资，VWAV飙涨近370%；乳腺癌药物实验效果积极，CELC大涨超167%；正式进军稳定币领域，MPU大涨超40%>>
07-29 19:19
Stereotaxis Receives FDA 510(k) Clearance For MAGiC Sweep Catheter
Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance
07-28 19:49
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
Stereotaxis has received FDA clearance for its MAGiC Sweep™ catheter, the first robotically navigated high-density electrophysiology mapping catheter. Designed to enhance complex arrhythmia diagnosis and treatment, MAGiC Sweep offers efficient high-density mapping with 20 electrodes, extended reach, precision, an atraumatic design, and improved workflow. Experts praise its potential to revolutionize cardiac ablation procedures, and Stereotaxis pl...
07-28 11:48
